Methicillin Resistant Staphylococcus Aureus Sacroiliac Joint Septic Arthritis in an Adult Patient Treated with

Ramy Rashed1, Fizan Younis1

  • 1Department of Orthopaedics and Traumatology, Royal Blackburn Hospital, Haslingden Road, Blackburn BB2 3HH.

Insights

This case study highlights a rare instance of sacroiliac joint septic arthritis in a patient with psoriasis. The infection, caused by Methicillin-Resistant Staphylococcus Aureus (MRSA), was successfully managed with the antibiotic Daptomycin.

Area of Science:

  • Infectious Diseases
  • Rheumatology
  • Orthopedic Surgery

Background:

  • Sacroiliac joint septic arthritis is a rare condition, accounting for 1-2% of all septic arthritis cases.
  • Diagnosis can be challenging due to non-specific symptoms and overlap with other conditions.
  • Psoriasis is an autoimmune disease that can be associated with various musculoskeletal complications.

Purpose of the Study:

  • To report a case of sacroiliac joint septic arthritis.
  • To describe a complicated case involving Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteremia and an iliopsoas abscess.
  • To highlight the successful conservative management with a novel antibiotic.

Main Methods:

  • Case report of a 50-year-old male patient.
  • Clinical presentation, diagnostic workup, and treatment course were documented.
  • Infection was confirmed and treated with Daptomycin.

Main Results:

  • The patient presented with symptoms suggestive of sacroiliac joint infection.
  • Diagnosed with sacroiliac joint septic arthritis, MRSA bacteremia, and an iliopsoas abscess.
  • Successful conservative treatment was achieved with Daptomycin.

Conclusions:

  • Sacroiliac joint septic arthritis, though rare, requires prompt diagnosis and management.
  • MRSA can be a causative agent, leading to severe complications like bacteremia and abscess formation.
  • Daptomycin is an effective therapeutic option for managing complicated cases of resistant bacterial arthritis.